Abstract

Lipoprotein glomerulopathy (LPG) is a dominant inherited kidney disorder characterized by lipoprotein thrombi in glomerular capillaries. Single-amino-acid mutations in apoE have been associated with the development of the disease, although the mechanism is unknown. In an effort to gain mechanistic insight linking the presence of such mutations and the development of LPG, we evaluated the effects of three of the most common apoE3 variants associated with this disease, namely R145P(Sendai), R147P(Chicago), and R158P(Osaka or Kurashiki), on the structural and conformational integrity of the protein. All three variants were found to have significantly reduced helical content, to expose a larger portion of hydrophobic surface to the solvent, and to be significantly thermodynamically destabilized, often lacking functionally relevant unfolding intermediates. Furthermore, all variants were aggregation prone and had enhanced sensitivity to protease digestion. Finally, although the variants were able to form discoidal lipoprotein particles, discrete subpopulations of poorly formed or aberrant particles were evident. Furthermore, these lipoprotein particles were thermodynamically destabilized and aggregation prone. Overall, our data suggest that these mutations induce a generalized unfolding of the N-terminal domain of apoE3 toward a molten-globule-like structure. ApoE3 N-terminal domain unfolding due to mutation may constitute a common mechanism underlying the protein's association with the pathogenesis of LPG.

Highlights

  • Lipoprotein glomerulopathy (LPG) is a dominant inherited kidney disorder characterized by lipoprotein thrombi in glomerular capillaries

  • The polymorphic background, as well as mutations in the apoE gene, have been linked with the pathogenesis of several diseases related to lipid metabolism, such as type III hyperlipoproteinemia, carotid atherosclerosis, diabetic dyslipidemia, and lipoprotein glomerulopathy (LPG) [15,16,17,18]

  • Wild-type apoE produced in this expression system has been shown to have biophysical properties identical to apoE produced by mammalian expression systems [39]

Read more

Summary

Introduction

Lipoprotein glomerulopathy (LPG) is a dominant inherited kidney disorder characterized by lipoprotein thrombi in glomerular capillaries. The polymorphic background, as well as mutations in the apoE gene, have been linked with the pathogenesis of several diseases related to lipid metabolism, such as type III hyperlipoproteinemia, carotid atherosclerosis, diabetic dyslipidemia, and lipoprotein glomerulopathy (LPG) [15,16,17,18]. Adenovirus-mediated gene transfer studies of apoE Sendai (R145P) in apoEdeficient mice resulted in distinct intra-glomerular depositions of apoE-containing lipoproteins, suggesting that apoE Sendai is an etiological cause of LPG [25]. This evidence suggests a direct association between apoE mutations and LPG, the mechanism that leads to deposition of lipoproteins in the glomerulus is unknown. Lack of knowledge regarding the functional and structural repercussions of LPG-associated mutations on apoE has impeded our understanding of a unified mechanism leading to LPG pathogenesis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call